Ohr Pharmaceutical Inc 4
4 · Ohr Pharmaceutical Inc · Filed Mar 12, 2015
Insider Transaction Report
Form 4
HIRSCHMAN ORIN
Director10% Owner
Transactions
- Award
Option
2015-03-10+84,000→ 84,000 totalExercise: $10.14From: 2015-03-10Exp: 2020-03-10→ Common Stock (84,000 underlying)
Holdings
- 138,200(indirect: By Children)
Common Stock, $0.0001 par value
- 100,000
Option
Exercise: $1.71From: 2012-03-09Exp: 2017-03-09→ Common Stock (100,000 underlying) - 1,506,747(indirect: By LLC)
Common Stock, $0.0001 par value
- 29,000(indirect: By LLC)
Warrant
Exercise: $3.60From: 2012-06-28Exp: 2017-06-28→ Common Stock (29,000 underlying)
Footnotes (2)
- [F1]63,000 options are currently unexercisable; 1/3rd will become exercisable on each of March 10, 2016, March 10, 2017 and March 10, 2018.
- [F2]Options granted pursuant to registrant's 2014 Stock Incentive Plan.